Ackermans & van Haaren NV
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Semi-annual Revenue
•
in mil. unless spec.Semi-annual Earnings Per Share
•
in mil. unless spec.Semi-annual Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Piet Dejonghe
- Full Time Employees
- 24,931
- Sector
- Industrial services
- Industry
- Engineering & construction
- Address
- Begijnenvest 113 Antwerp BU Belgium 2000
- IPO Date
- Jun 20, 1984
- Website
- avh.be
- Similar Companies
- Business
- Ackermans & Van Haaren NV is a diversified Belgian investment group that engages in long-term strategic participations across multiple sectors including marine engineering and contracting; private banking; real estate and senior care; energy and resources; and growth capital. The group holds significant stakes in core subsidiaries such as DEME, a leading global dredging, marine construction, and environmental solutions provider involved in infrastructure projects, renewable energy, and deep-sea minerals; CFE, a Belgian construction group specializing in building, infrastructure, and real estate development; Delen Private Bank, one of Belgium's largest independent private asset managers offering discretionary portfolio management primarily to entrepreneurs and liberal professionals, alongside JM Finn in the UK; Bank Van Breda, a niche bank tailored for entrepreneurs, liberal professions, and health care professionals in Belgium; Nextensa, a listed integrated real estate developer and manager focused on residential, office, and retail properties; SIPEF, an agroindustrial company specializing in sustainable tropical agriculture, particularly palm oil and bananas across Asia, Africa, and South America; and various growth capital investments in family-controlled companies with high potential such as those in the AvH direct portfolio. Operations span globally with key activities in Europe, Asia, Africa, and other regions, targeting institutional, entrepreneurial, and private clients. Founded in 1876 and headquartered in Antwerp, Belgium, the company listed on Euronext Brussels is included in the BEL20 and DJ Stoxx 600 indices. Recent developments include participation in a STAR Capital-led consortium that completed the acquisition of V.Group, a global maritime services provider, in September 2024 to bolster marine-related growth; and the acquisition of a 40% stake in IQIP Holding, a Dutch pipeline solutions firm, from HAL Investments for EUR 100 million in March 2024, enhancing its energy and infrastructure exposure.
Company News
Ackermans & van Haaren: all items on the agenda of the ASM approved, incl. gross dividend of €4.60 per share
Ackermans & van Haaren (Trading Update Q1 2026): Strong start to the year of core participations. Confirmation of guidance.
Ackermans & van Haaren ends a successful year 2025 with a net profit of 593 million euros (+29%)
Ackermans & van Haaren Trading Update 3Q2025: Excellent results of core participations, FY2025 Outlook confirmed
Ackermans & van Haaren invests 22 million euros in VKC Nuts
Ackermans & van Haaren supports MRM Health's Series B financing round of 55 million euros
Ackermans & van Haaren commits 20 million US dollars to the second fund of Venturi Partners
Ackermans & van Haaren: First-Half 2025 Results
Ackermans & van Haaren: the General Shareholders' Meeting approves all proposed resolutions by a vast majority
Ackermans & van Haaren (Trading Update Q1 2025): AvH reports solid start to the year and confirms guidance
Ackermans & van Haaren: publication of a transparency notification
Ackermans & van Haaren grows net profit by 15% in 2024 to 460 million euros.
Ackermans & van Haaren Trading Update Q3 2024 - AvH is on track towards a net profit well above 400 million euros
Ackermans & van Haaren and the Delen family confirm their long-term partnership with updated shareholder arrangements in respect of Delen Private Bank and Bank J. Van Breda & Co
Ackermans & van Haaren invests an additional 5 million euros in Biotalys
Ackermans & van Haaren: Outstanding results in core participations result in a strong increase of AvH's net profit for 1H2024 to EUR 200 million (+17%)
Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company
Ackermans & van Haaren: the General Shareholders' Meeting approves all proposed resolutions by a large majority
Ackermans & van Haaren reports outstanding Q1-results at both DEME and at the private banks Delen and Van Breda, and gives confirmation of guidance: net profit of 2024 expected to be higher than last year
Ackermans & van Haaren realised a net profit of 399.2 million euros, thanks to a record performance of its core participations